BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1696 related articles for article (PubMed ID: 16868517)

  • 1. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endolymphatic sac decompression as a treatment for Meniere's disease.
    Durland WF; Pyle GM; Connor NP
    Laryngoscope; 2005 Aug; 115(8):1454-7. PubMed ID: 16094123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of hearing preservation after endolymphatic mastoid sac surgery for Meniere's disease.
    Sun GH; Leung R; Samy RN; McAfee JS; Hearst MJ; Savage CR; Choo DI; Pensak ML
    Laryngoscope; 2010 Mar; 120(3):591-7. PubMed ID: 20131368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endolymphatic sac surgery for Ménière's disease: long-term results after primary and revision surgery.
    Wetmore SJ
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1144-8. PubMed ID: 19015441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of quality of life after intratympanic streptomycin injection in patients with Ménière's disease.
    Jung J; Chun J; Kim N; Kim Y; Lee WS
    Otol Neurotol; 2008 Sep; 29(6):816-23. PubMed ID: 18617871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endolymphatic mastoid shunt versus endolymphatic sac decompression for Ménière's disease.
    Brinson GM; Chen DA; Arriaga MA
    Otolaryngol Head Neck Surg; 2007 Mar; 136(3):415-21. PubMed ID: 17321870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality-of-life assessment of Ménière's disease patients after surgical labyrinthectomy.
    Diaz RC; LaRouere MJ; Bojrab DI; Zappia JJ; Sargent EW; Shaia WT
    Otol Neurotol; 2007 Jan; 28(1):74-86. PubMed ID: 16985479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sac surgery results as a function of preoperative distress level.
    Tyagi I; Goyal A; Syal R
    Otol Neurotol; 2006 Oct; 27(7):951-5. PubMed ID: 16788426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endolymphatic duct blockage: quality of life assessment of a novel surgical technique for Ménière disease.
    Gabra N; Asmar MH; Berbiche D; Saliba I
    Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):2965-73. PubMed ID: 26742910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endolymphatic sac enhancement surgery in elderly patients with Ménière's disease.
    Sajjadi H; Paparella MM; Williams T
    Ear Nose Throat J; 1998 Dec; 77(12):975-82. PubMed ID: 9879137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 10-year review of endolymphatic sac surgery for intractable meniere disease.
    Hu A; Parnes LS
    J Otolaryngol Head Neck Surg; 2010 Aug; 39(4):415-21. PubMed ID: 20643008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caloric function after endolymphatic sac surgery.
    Ulubil SA; Eshraghi AA; Telischi FF; Angeli SI; Balkany TJ; Joy JJ
    Laryngoscope; 2008 Feb; 118(2):295-9. PubMed ID: 18091339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of endolymphatic mastoid shunt surgery in patients with intractable Ménière's disease.
    Yu MS; Lee KS; Chung JW
    Otolaryngol Head Neck Surg; 2009 Aug; 141(2):237-42. PubMed ID: 19643258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple semicircular canal occlusion for the treatment of Ménière's disease.
    Yin S; Chen Z; Yu D; Wu Y; Shi H; Zhou H; Wang J
    Acta Otolaryngol; 2008 Jul; 128(7):739-43. PubMed ID: 18568514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
    Rajan GP; Din S; Atlas MD
    J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of endolymphatic sac to mastoid shunt surgery for Menière's disease refractory to medical therapy.
    Arenberg IK
    Am J Otol; 1987 Jul; 8(4):335-44. PubMed ID: 3631243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 85.